Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Azevedo, Orleâncio Gomes R ^a,b   Oliveira, Renato André C ^a,b   Oliveira, Bruna C ^a,b   Zaja Milatovic, Snjezana ^a   Araújo, Celina V ^b   Wong, Deysi Viviana T ^b   Costa, Tiê B ^b   Lucena, Herene Barros M ^a   Lima Júnior, Roberto César P ^b   Ribeiro, Ronaldo A ^b   Warren, Cirle A ^a   Lima, Aldo Ângelo M ^a,b   Vitek, Michael P ^c   Guerrant, Richard L ^a   Oriá, Reinaldo B ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c DUKE UNIVERSITY   (United States)

Author keywords

5 fluorouracil; Apolipoprotein e; Cytokines; Inflammation; Mucositis

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E; APOLIPOPROTEIN E COG 133 MIMETIC PEPTIDE; D 4F MIMETIC PEPTIDE; FLUOROURACIL; GLUTAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN IEC 6; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; ENTERITIS; ENTEROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOLOGY; IN VITRO STUDY; INFLAMMATORY INFILTRATE; INTESTINAL MUCOSITIS; INTESTINE VILLUS; KNOCKOUT MOUSE; MOLECULAR BIOLOGY; MONOLAYER CULTURE; MOUSE; MUCOSA INFLAMMATION; NICK END LABELING; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SMALL INTESTINE; SWISS WEBSTER MOUSE; TREATMENT DURATION;

ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; BIOMIMETIC MATERIALS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; FLUOROURACIL; INTESTINAL DISEASES; JEJUNUM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCOSITIS; PEPTIDE FRAGMENTS; PEROXIDASE; RATS;

EID: 84864370840     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-35     Document Type: Article

References (42)

1. Bowen JM, Gibson RJ, Cummins AG, Keefe DM. Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage. Support Care Cancer 2006, 14(7):713-731. 10.1007/s00520-005-0004-7, 16453135.
2. Sonis ST, Peterson RL, Edwards LJ, Lucey CA, Wang L, Mason L, Login G, Ymamkawa M, Moses G, Bouchard P, Hayes LL, Bedrosian C, Dorner AJ. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol 2000, 36(4):373-381. 10.1016/S1368-8375(00)00012-9, 10899677.
3. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003, 3(5):330-338. 10.1038/nrc1074, 12724731.
4. Lombardi L, Morelli F, Cinieri S, Santini D, Silvestris N, Fazio N, Orlando L, Tonini G, Colucci G, Maiello E. Adjuvant colon cancer chemotherapy: where we are and where we'll go. Cancer Treat Rev 2010, 36(Suppl 3):S34-S41.
5. Soares PM, Mota JM, Gomes AS, Oliveira RB, Assreuy AM, Brito GA, Santos AA, Ribeiro RA, Souza MH. Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemother Pharmacol 2008, 63(1):91-98. 10.1007/s00280-008-0715-9, 18324404.
6. Carneiro-Filho BA, Oria RB, Wood RK, Brito GA, Fujii J, Obrig T, Lima AA, Guerrant RL. Alanyl-glutamine hastens morphologic recovery from 5-fluorouracil-induced mucositis in mice. Nutrition 2004, 20(10):934-941. 10.1016/j.nut.2004.06.016, 15474885.
7. Braga-Neto MB, Warren CA, Oria RB, Monteiro MS, Maciel AA, Brito GA, Lima AA, Guerrant RL. Alanyl-glutamine and glutamine supplementation improves 5-fluorouracil-induced intestinal epithelium damage in vitro. Dig Dis Sci 2008, 53(10):2687-2696. 10.1007/s10620-008-0215-0, 18320312.
8. Lynch JR, Tang W, Wang H, Vitek MP, Bennett ER, Sullivan PM, Warner DS, Laskowitz DT. APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem 2003, 278(49):48529-48533. 10.1074/jbc.M306923200, 14507923.
9. Laskowitz DT, McKenna SE, Song P, Wang H, Durham L, Yeung N, Christensen D, Vitek MP. COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury. J Neurotrauma 2007, 24(7):1093-1107. 10.1089/neu.2006.0192, 17610350.
10. Wang H, Durham L, Dawson H, Song P, Warner DS, Sullivan PM, Vitek MP, Laskowitz DT. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction. Neuroscience 2007, 144(4):1324-1333. 10.1016/j.neuroscience.2006.11.017, 17187933.
11. Li FQ, Sempowski GD, McKenna SE, Laskowitz DT, Colton CA, Vitek MP. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis. J Pharmacol Exp Ther 2006, 318(3):956-965. 10.1124/jpet.106.103671, 16740622.
12. Singh K, Chaturvedi R, Barry DP, Coburn LA, Asim M, Lewis ND, Piazuelo MB, Washington MK, Vitek MP, Wilson KT. The apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis. J Biol Chem 2011, 286(5):3839-3850. 10.1074/jbc.M110.176719, 3030385, 21115487.
13. Leitao RF, Ribeiro RA, Bellaguarda EA, Macedo FD, Silva LR, Oria RB, Vale ML, Cunha FQ, Brito GA. Role of nitric oxide on pathogenesis of 5-fluorouracil induced experimental oral mucositis in hamster. Cancer Chemother Pharmacol 2007, 59(5):603-612. 10.1007/s00280-006-0301-y, 16944152.
14. Melo ML, Brito GA, Soares RC, Carvalho SB, Silva JV, Soares PM, Vale ML, Souza MH, Cunha FQ, Ribeiro RA. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide. Cancer Chemother Pharmacol 2008, 61(5):775-784. 10.1007/s00280-007-0534-4, 17624531.
15. Coutinho BP, Oria RB, Vieira CM, Sevilleja JE, Warren CA, Maciel JG, Thompson MR, Pinkerton RC, Lima AA, Guerrant RL. Cryptosporidium infection causes undernutrition and, conversely, weanling undernutrition intensifies infection. J Parasitol 2008, 94(6):1225-1232. 10.1645/GE-1411.1, 3070954, 18576767.
16. Van Lenten BJ, Wagner AC, Anantharamaiah GM, Navab M, Reddy ST, Buga GM, Fogelman AM. Apolipoprotein A-I mimetic peptides. Curr Atheroscler Rep 2009, 11(1):52-57. 10.1007/s11883-009-0008-8, 2856617, 19080728.
17. Faheina-Martins GV, da Silveira AL, Ramos MV, Marques-Santos LF, Araujo DA. Influence of fetal bovine serum on cytotoxic and genotoxic effects of lectins in MCF-7 cells. J Biochem Mol Toxicol 2011, 25(5):290-296. 10.1002/jbt.20388, 21523858.
18. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH, Mailliard JA. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 1995, 122(5):321-326.
19. Raftery L, Goldberg RM. Optimal delivery of cytotoxic chemotherapy for colon cancer. Cancer J 2010, 16(3):214-219. 10.1097/PPO.0b013e3181ddc5ac, 20526099.
20. Duncan M, Grant G. Oral and intestinal mucositis - causes and possible treatments. Aliment Pharmacol Ther 2003, 18(9):853-874. 10.1046/j.1365-2036.2003.01784.x, 14616150.
21. Oria RB, Vieira CMG, Pinkerton RC, De Castro-Costa CM, Lopes MB, Hussaini I, Shi W, Brito GAC, Lima AAM, Guerrant RL. Apolipoprotein E knockout mice have accentuated malnutrition with mucosal disruption and blunted insulin-like growth factor responses to refeeding. Nutr Res 2007, 26:427-435.
22. Strauch ED, Bass BL, Rao JN, Vann JA, Wang JY. NF-kappaB regulates intestinal epithelial cell and bile salt-induced migration after injury. Ann Surg 2003, 237(4):494-501. 1514469, 12677145.
23. Theillaumas A, Blanc M, Couderc C, Poncet G, Bazzi W, Bernard C, Cordier-Bussat M, Scoazec JY, Roche C. Relation between menin expression and NF-kappaB activity in an intestinal cell line. Mol Cell Endocrinol 2008, 291(1-2):109-115.
24. Lindsay RJ, Geier MS, Yazbeck R, Butler RN, Howarth GS. Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis. Br J Nutr 2010, 104(4):513-519. 10.1017/S000711451000084X, 20377926.
25. Soares PM, Lima-Junior RC, Mota JM, Justino PF, Brito GA, Ribeiro RA, Cunha FQ, Souza MH. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Cancer Chemother Pharmacol 2011, 68(3):713-720. 10.1007/s00280-010-1540-5, 21153821.
26. Jofre-Monseny L, Minihane AM, Rimbach G. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 2008, 52(1):131-145. 10.1002/mnfr.200700322, 18203129.
27. Chuang K, Elford EL, Tseng J, Leung B, Harris HW. An expanding role for apolipoprotein E in sepsis and inflammation. Am J Surg 2010, 200(3):391-397. 10.1016/j.amjsurg.2009.10.017, 2909338, 20409531.
28. Rensen PC, Oosten M, Bilt E, Eck M, Kuiper J, Berkel TJ. Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo. J Clin Invest 1997, 99(10):2438-2445. 10.1172/JCI119427, 508084, 9153287.
29. Van OM, Rensen PC, Van Amersfoort ES, Van EM, Van Dam AM, Breve JJ, Vogel T, Panet A, Van Berkel TJ, Kuiper J. Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis. J Biol Chem 2001, 276(12):8820-8824. 10.1074/jbc.M009915200, 11136731.
30. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996, 87(6):2095-2147.
31. Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?. Cancer Chemother Pharmacol 2009, 63(2):239-251. 10.1007/s00280-008-0732-8, 18351341.
32. Singh K, Chaturvedi R, Barry DP, Coburn LA, Asim M, Lewis ND, Piazuelo MB, Washington MK, Vitek MP, Wilson KT. The apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis. J Biol Chem 2011, 286(5):3839-3850. 10.1074/jbc.M110.176719, 3030385, 21115487.
33. Singh K, Chaturvedi R, Asim M, Barry DP, Lewis ND, Vitek MP, Wilson KT. The apolipoprotein E-mimetic peptide COG112 inhibits the inflammatory response to Citrobacter rodentium in colonic epithelial cells by preventing NF-kappaB activation. J Biol Chem 2008, 283(24):16752-16761. 10.1074/jbc.M710530200, 2423260, 18417477.
34. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996, 87(6):2095-2147.
35. Navab M, Reddy ST, Anantharamaiah GM, Imaizumi S, Hough G, Hama S, Fogelman AM. Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally. J Lipid Res 2011, 52(6):1200-1210. 10.1194/jlr.M013144, 3090241, 21444758.
36. Christensen DJ, Ohkubo N, Oddo J, Van Kanegan MJ, Neil J, Li F, Colton CA, Vitek MP. Apolipoprotein E and peptide mimetics modulate inflammation by binding the SET protein and activating protein phosphatase 2A. J Immunol 2011, 186(4):2535-2542. 10.4049/jimmunol.1002847, 21289314.
37. Madeira A, Pommet JM, Prochiantz A, Allinquant B. SET protein (TAF1beta, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor protein cytoplasmic subdomain. FASEB J 2005, 19(13):1905-1907.
38. Van HF, Festjens N, Declercq W, Vandenabeele P. Tumor necrosis factor-mediated cell death: to break or to burst, that's the question. Cell Mol Life Sci 2010, 67(10):1567-1579. 10.1007/s00018-010-0283-0, 20198502.
39. Miwa M, Kojima T, Naruse T. Serum factors attenuating the anti-tumor activity of 5-fluorouracil. Cancer Biother Radiopharm 2001, 16(4):317-322. 10.1089/108497801753131390, 11603002.
40. Colton CA, Brown CM, Czapiga M, Vitek MP. Apolipoprotein-E allele-specific regulation of nitric oxide production. Ann N Y Acad Sci 2002, 962:212-225. 10.1111/j.1749-6632.2002.tb04070.x, 12076977.
41. Colton CA, Brown CM, Cook D, Needham LK, Xu Q, Czapiga M, Saunders AM, Schmechel DE, Rasheed K, Vitek MP. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. Neurobiol Aging 2002, 23(5):777-785. 10.1016/S0197-4580(02)00016-7, 12392781.
42. Hoane MR, Kaufman N, Vitek MP, McKenna SE. COG1410 improves cognitive performance and reduces cortical neuronal loss in the traumatically injured brain. J Neurotrauma 2009, 26(1):121-129. 10.1089/neu.2008.0565, 2749004,2749004, 19119914.